C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2614603
Corticotropin releasing factor (CRF) antagonists of formula (I) or (II) and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
L'invention porte sur des antagonistes du facteur de libération de la corticotropine (CRF) présentant la formule (I) ou (II) et leur utilisation dans le traitement de l'anxiété, de la dépression et d'autres affections psychiatriques, neurologiques, de même que le traitement de maladies immunologiques, cardiovasculaires ou cardiaques ainsi que l'hypersensibilité colonique associée à une perturbation ou un stress psychopathologique.
Arvanitis Argyrios Georgios
Chorvat Robert John
Gilligan Paul Joseph
He Liqi
Bristol-Myers Squibb Pharma Company
Dimock Stratton Llp
LandOfFree
Azolo triazines and pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azolo triazines and pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azolo triazines and pyrimidines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1376551